DigiTx Partners invests in early-stage digital health companies that leverage technology, data, and digital therapeutics to address healthcare inefficiencies. Their focus is on data-driven solutions that generate competitive insights and enhance patient outcomes, particularly in personalized medicine, data analytics, and digital therapeutics.
About DigiTx Partners
DigiTx Partners is a healthcare and life sciences venture capital firm with a thesis spanning digital health, healthtech, and adjacent technology-enabled healthcare companies, with website, LinkedIn, and Crunchbase footprint. The firm has been an active investor across digital health categories, including clinical software, patient engagement, healthcare AI, and selective therapeutics-adjacent technology investments. For healthcare AI founders, DigiTx is a thesis-aligned potential lead or co-lead at seed and Series A, with check sizes typically in the $1M to $5M range, capable of leading rounds and providing meaningful follow-on through Series B. The strongest fit is for healthcare AI companies with clear clinical or commercial validation, including digital therapeutics with regulatory clarity, AI-driven clinical decision support with paying enterprise customers, or healthcare workflow AI with credible provider commercial traction. Founders building pre-clinical biotech, capital-intensive devices, or pure consumer wellness without clinical evidence are less likely to fit. The firm’s value-add is most credible around healthcare regulatory and reimbursement strategy, provider and payer commercial relationships, and connection to healthcare-specific follow-on capital. Founders should be prepared for substantive healthcare diligence including clinical evidence review, reimbursement pathway analysis, and provider customer references, in addition to standard SaaS metrics. Entry path is LinkedIn outreach to the partners, the website inquiry form, or warm referral from a portfolio CEO or healthcare ecosystem operator. This is a credible thesis-aligned destination for healthcare AI founders with clinical depth; founders without clinical or commercial validation should plan to layer in clinical pilots and evidence before approaching DigiTx for a meaningful round.
Founder reviews
Healthcare AI tools backed by DigiTx Partners
Tools made by companies in DigiTx Partners's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in DigiTx Partners's portfolio not currently in our directory.
- Auxira
- Ayble Health
- Biobase
- CardioSignal · 2024
- Cerula Care · 2025
- Ciba Health · 2024
- Felt · 2024
- G-Tech Medical
Team
Pitch / review this investor
Have you raised from DigiTx Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).